Mostrar el registro sencillo del ítem

dc.contributor.authorPech-Puch, Dawrin
dc.contributor.authorPérez-Povedano, Mar
dc.contributor.authorMartínez Guitian, Marta
dc.contributor.authorLasarte Monterrubio, Cristina
dc.contributor.authorVázquez Ucha, Juan Carlos
dc.contributor.authorBou Arévalo, Germán 
dc.contributor.authorRodríguez, Jaime
dc.contributor.authorBECEIRO CASAS, ALEJANDRO JOSE 
dc.contributor.authorJimenez, Carlos
dc.date.accessioned2022-03-08T08:49:44Z
dc.date.available2022-03-08T08:49:44Z
dc.date.issued2020
dc.identifier.issn1660-3397
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/32585891es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16201
dc.description.abstractThe pyrrole-imidazoles, a group of alkaloids commonly found in marine sponges belonging to the genus Agelas, display a wide range of biological activities. Herein, we report the first chemical study of the secondary metabolites of the sponge A. dilatata from the coastal area of the Yucatan Peninsula (Mexico). In this study, we isolated eight known alkaloids from an organic extract of the sponge. We used NMR and MS analysis and comparison with existing databases to characterize the alkaloids: ageliferin (1), bromoageliferin (2), dibromoageliferin (3), sceptrin (4), nakamuric acid (5), 4-bromo-1H-pyrrole-2-carboxylic acid (6), 4,5-dibromopyrrole-2-carboxylic acid (7) and 3,7-dimethylisoguanine (8). We also evaluated, for the first time, the activity of these alkaloids against the most problematic multidrug-resistant (MDR) pathogens, i.e., the Gram-negative bacteria Pseudomonas aeruginosa, Klebsiella pneumoniae and Acinetobacter baumannii. Bromoageliferin (2) displayed significant activity against P. aeruginosa. Comparison of the antibacterial activity of ageliferins 1-3 (of similar structure) against P. aeruginosa revealed some relationship between structure and activity. Furthermore, in in vitro assays, 2 inhibited growth and biofilm production in clinical strains of P. aeruginosa. Moreover, 2 increased the survival time in an in vivo Galleria mellonella model of infection. The findings confirm bromoageliferin (2) as a potential lead for designing new antibacterial drugs.en
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshBiofilms*
dc.subject.meshPorifera*
dc.subject.meshAcinetobacter baumannii*
dc.subject.meshMolecular Structure*
dc.subject.meshAnti-Bacterial Agents*
dc.subject.meshAnimals*
dc.subject.meshAlkaloids*
dc.subject.meshPseudomonas aeruginosa*
dc.subject.meshAgelas*
dc.subject.meshKlebsiella pneumoniae*
dc.titleIn Vitro and In Vivo Assessment of the Efficacy of Bromoageliferin, an Alkaloid Isolated from the Sponge Agelas dilatata, against Pseudomonas aeruginosaen
dc.typeJournal Articlees
dc.authorsophosPech-Puch, Dawrin;Pérez-Povedano, Mar;Martinez-Guitian, Marta;Lasarte-Monterrubio, Cristina;Vázquez-Ucha, Juan Carlos;Bou, Germán;Rodríguez, Jaime;Beceiro, Alejandro;Jimenez, Carlos
dc.identifier.doi10.3390/md18060326
dc.identifier.pmid32585891
dc.identifier.sophos35829
dc.issue.number6es
dc.journal.titleMarine Drugses
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario de A Coruña::Microbioloxíaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Biomédica da Coruña (INIBIC)es
dc.relation.publisherversionhttps://mdpi-res.com/d://attachment/marinedrugs/marinedrugs-18-00326/article://deploy/marinedrugs-18-00326.pdfes
dc.rights.accessRightsopenAccess
dc.subject.decsanimales*
dc.subject.decsestructura molecular*
dc.subject.decsPseudomonas aeruginosa*
dc.subject.decsalcaloides*
dc.subject.decsAgelas*
dc.subject.decsPorifera*
dc.subject.decsbiofilms*
dc.subject.decsantibacterianos*
dc.subject.decsAcinetobacter baumannii*
dc.subject.decsKlebsiella pneumoniae*
dc.subject.keywordCHUACes
dc.subject.keywordINIBICes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number18es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional